The Latest Breaking News from Nasdaq

Upgrades

ChromaDex Corp (NASDAQ:CDXC) has agreed to establish a joint venture through its wholly-owned subsidiary ChromaDex Asia Limited.  ChromaDex Asia is expected to assume the distribution agreement with Sinopharm Xingsha relating to the commercialization of Tru Niagen in mainland China and its territories, excluding Hong Kong, Macau, and Taiwan.  Also See: ChromaDex Shares Gain On Niagen Supply Pact With…

Analysts have provided the following ratings for Intuit (NASDAQ:INTU) within the last quarter:

Zoom Video Communications (NASDAQ:ZM) is set to give its latest quarterly earnings report on Monday, 2022-05-23. Here's what investors need to know before the announcement. Analysts estimate that Zoom Video Communications will report an earnings per share (EPS) of $0.87.

According to Benzinga Pro, during Q1, Encore Capital Gr (NASDAQ:ECPG) earned $175.75 million, a 131.0% increase from the preceding quarter. Encore Capital Gr also posted a total of $499.68 million in sales, a 39.85% increase since Q4.

According to data from Benzinga Pro, during Q1, Global Blood Therapeutics's (NASDAQ:GBT) reported sales totaled $55.16 million. Despite a 7.03% increase in earnings, the company posted a loss of $81.42 million.

Upland Software (NASDAQ:UPLD) brought in sales totaling $78.72 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 205.59%, resulting in a loss of $22.83 million.

Pulled from Benzinga Pro data, Carlyle Group (NASDAQ:CG) posted Q1 earnings of $594.80 million, an increase from Q4 of 9.93%. Sales dropped to $779.50 million, a 58.87% decrease between quarters.

According to Benzinga Pro, during Q1, eXp World Holdings (NASDAQ:EXPI) earned $8.86 million, a 42.65% increase from the preceding quarter. eXp World Holdings's sales decreased to $1.01 billion, a 6.13% change since Q4.

Benzinga Pro data, Morphic Holding (NASDAQ:MORF) reported Q1 sales of $2.38 million. Earnings fell to a loss of $31.48 million, resulting in a 47.11% decrease from last quarter.

Benzinga Pro data, Tellurian (NASDAQ:TELL) reported Q1 sales of $146.94 million. Earnings fell to a loss of $66.61 million, resulting in a 61.57% decrease from last quarter.